PDCD1LG2 and kidney cancer: In environments lacking adaptive immunity, exosomal PD-L2 from kidney cancer cells has been paradoxically shown to inhibit tumor growth and metastasis, demonstrating that their effects are highly dependent on the host immune context (Zhang et al., 2022).